Xenografts created by the injection of CD19+ CD138- myeloma cell fractions showed partial CD138 re-expression in the primary engrafted tumor, whereas CD138 expression was almost non-existent in circulating B cells, suggesting that CD138 expression is dependent on environmental cues (30, 31). Here, CD19 is linked to plasma cell myeloma.